LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
24h
Current
Min
4.3
Max
4.3
Recommendations | Buy |
|---|---|
12 Months Forecast | +11.93% upside |
By Acuity
50%
50%
165 / 374 Ranking in Healthcare
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
24 paź 2025, 13:04 UTC
Eli Lilly Agrees to Acquire Adverum Biotechnologies
DJ
Read
9 gru 2025, 13:32 UTC
Eli Lilly: Parties Expect to Consummate the Acquisition on Dec 9 >LLY
DJ
Read
9 gru 2025, 13:32 UTC
Lilly and Purchaser Accepted for Payment, and Will Promptly Pay, for All Shrs
DJ
Read
9 gru 2025, 13:29 UTC
Lilly and Adverum Announce Expiration and Completion of Adverum Tender Offer and Acquisition
DJ
Read
24 paź 2025, 12:34 UTC
Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY
DJ
Read
24 paź 2025, 12:34 UTC
Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY
DJ
Read
24 paź 2025, 12:33 UTC
Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY
DJ
Read
24 paź 2025, 12:30 UTC
Lilly To Acquire Adverum Biotechnologies >LLY ADVM
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 4.88 USD 11.93%
High 5.5 USD
Low 4 USD
Based on 5 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.
By TipRanks
Buy
5 ratings
2
Buy
3
Hold
0
Sell
Based on 5 analysts giving stock ratings to Adverum Biotechnologies Inc - Dist in the past 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
$